These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 21574259)

  • 61. Immunocytochemical typification of mesothelial cells in effusions: in vivo and in vitro models.
    Ferrandez-Izquierdo A; Navarro-Fos S; Gonzalez-Devesa M; Gil-Benso R; Llombart-Bosch A
    Diagn Cytopathol; 1994; 10(3):256-62. PubMed ID: 7519540
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cytopathologic differential diagnosis of malignant mesothelioma, adenocarcinoma and reactive mesothelial cells: A logistic regression analysis.
    Cakir E; Demirag F; Aydin M; Unsal E
    Diagn Cytopathol; 2009 Jan; 37(1):4-10. PubMed ID: 18973123
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Distinction between carcinoma cells and mesothelial cells in serous effusions. Usefulness of immunohistochemistry.
    Tickman RJ; Cohen C; Varma VA; Fekete PS; DeRose PB
    Acta Cytol; 1990; 34(4):491-6. PubMed ID: 2197840
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An Updated Contextual Approach to Mesothelial Proliferations in Pleural Effusion Cytology Leveraging Morphology, Ancillary Studies, and Novel Biomarkers.
    Miller LJ; Holmes IM; Lew M
    Arch Pathol Lab Med; 2024 Apr; 148(4):409-418. PubMed ID: 37622452
    [TBL] [Abstract][Full Text] [Related]  

  • 65. CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause.
    Wang XF; Wu YH; Wang MS; Wang YS
    Asian Pac J Cancer Prev; 2014; 15(1):363-8. PubMed ID: 24528057
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Calretinin staining pattern aids in the differentiation of mesothelioma from adenocarcinoma in serous effusions.
    Chhieng DC; Yee H; Schaefer D; Cangiarella JF; Jagirdar J; Chiriboga LA; Jagirdar J; Chiriboga LA; Cohen JM
    Cancer; 2000 Jun; 90(3):194-200. PubMed ID: 10896333
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Diagnostic Accuracy of a Limited Immuno-panel of Calretinin and Ber-EP4 for Diagnosis of Malignant Effusions.
    Khurram N; Anis T; Yusuf NW
    J Coll Physicians Surg Pak; 2019 Jan; 29(1):33-36. PubMed ID: 30630566
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Diagnostic value of metabolic phenotypes in malignant pleural effusions: expression of GLUT1 and CAIX by immunocytochemistry.
    Liao ND; Shieh JM; Lee WY
    Cancer Cytopathol; 2011 Oct; 119(5):346-53. PubMed ID: 21442770
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The importance of EZH2 and MOC-31 expression in the differential diagnosis of benign and malignant effusions.
    Sadullahoglu C; Nart D; Veral A
    Diagn Cytopathol; 2017 Feb; 45(2):118-124. PubMed ID: 28024110
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Significance of epithelial membrane antigen in the work-up of problematic serous effusions.
    Singh HK; Silverman JF; Berns L; Haddad MG; Park HK
    Diagn Cytopathol; 1995 Jul; 13(1):3-7. PubMed ID: 7587872
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ancillary studies in pleural, pericardial, and peritoneal effusion cytology.
    Sundling KE; Cibas ES
    Cancer Cytopathol; 2018 Aug; 126 Suppl 8():590-598. PubMed ID: 30156768
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Differential expression of the 67 kilodalton laminin receptor in epithelioid malignant mesothelioma and carcinomas that spread to serosal cavities.
    Reich R; Vintman L; Nielsen S; Kaern J; Bedrossian C; Berner A; Davidson B
    Diagn Cytopathol; 2005 Nov; 33(5):332-7. PubMed ID: 16240397
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma.
    Kato Y; Tsuta K; Seki K; Maeshima AM; Watanabe S; Suzuki K; Asamura H; Tsuchiya R; Matsuno Y
    Mod Pathol; 2007 Feb; 20(2):215-20. PubMed ID: 17192790
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Markers for metastatic adenocarcinoma in serous effusion specimens.
    Shield PW; Callan JJ; Devine PL
    Diagn Cytopathol; 1994; 11(3):237-45. PubMed ID: 7532566
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunocytochemical utility of claudin-4 versus those of Ber-EP4 and MOC-31 in effusion cytology.
    Oda T; Ogata S; Kawaguchi S; Minabe S; Dokyu M; Takahashi H; Kumazawa F; Shimazaki H; Takano M; Hase K; Ozeki Y; Kanoh S; Nakanishi K
    Diagn Cytopathol; 2016 Jun; 44(6):499-504. PubMed ID: 27015745
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The value of epithelial membrane antigen expression in separating benign mesothelial proliferation from malignant mesothelioma: a comparative study.
    Saad RS; Cho P; Liu YL; Silverman JF
    Diagn Cytopathol; 2005 Mar; 32(3):156-9. PubMed ID: 15690334
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Calretinin. A selective marker of normal and neoplastic mesothelial cells in serous effusions.
    Barberis MC; Faleri M; Veronese S; Casadio C; Viale G
    Acta Cytol; 1997; 41(6):1757-61. PubMed ID: 9390137
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Scoring system for differential diagnosis of malignant mesothelioma and reactive mesothelial cells on cytology specimens.
    Kimura N; Dota K; Araya Y; Ishidate T; Ishizaka M
    Diagn Cytopathol; 2009 Dec; 37(12):885-90. PubMed ID: 19572412
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Diagnostic Value of the EZH2 Immunomarker in Malignant Effusion Cytology.
    Ang PP; Tan GC; Karim N; Wong YP
    Acta Cytol; 2020; 64(3):248-255. PubMed ID: 31352449
    [TBL] [Abstract][Full Text] [Related]  

  • 80. MMP-7 is a highly specific negative marker for benign and malignant mesothelial cells in serous effusions.
    Davidson B; Stavnes HT; Hellesylt E; Hager T; Zeppa P; Pinamonti M; Wohlschlaeger J
    Hum Pathol; 2016 Jan; 47(1):104-8. PubMed ID: 26520416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.